Should the usual threshold for prostate biopsy be lowered from 4.0 to 2.5 ng/mL for healthy men with a life expectancy of well over 10 years?

Share this article:

The National Cancer Institute estimated that 240,890 men would be diagnosed with prostate cancer in the United States in 2011. Many clinicians believe the disease is being overdiagnosed and overtreated, yet some researchers have advocated decreasing the PSA threshold for prostate biopsy from the conventional 4.0 ng/mL to 2.5 ng/mL in an attempt to pick up prostate cancers that are now being missed. Critics say this could exacerbate the problem of overdiagnosis and lead to even more men being treated unnecessarily.

Renal & Urology News would like to know what you think, so please answer the following poll question.

Leave a comment below on why you chose your answer. If your answer doesn't match one of our choices, please let us know why.

Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

Are you surprised that targeted therapeutics for metastatic renal cell carcinoma (RCC) have not improved survival?

Are you surprised that targeted therapeutics for metastatic ...

A study found that targeted therapeutic agents for treating metastatic RCC has not led to an improvement in survival rates.

Do drug stores have an ethical obligation to stop selling tobacco products?

Do drug stores have an ethical obligation to ...

CVS announced that it would no longer sell cigarettes or other tobacco products at its stores.

When was the last time you performed a venipuncture for a routine blood test?

When was the last time you performed a ...

Millions of blood tests are performed annually, many to monitor PSA levels following prostate cancer treatment or to check uric levels.